Shire gets FDA approval to market ADHD drug for adults in U.S.

08/13/2004 | Scotsman (Edinburgh), The

Scotland's Shire Pharmaceuticals announced it has received approval from the FDA for the sale of its Adderall XR attention deficit hyperactivity disorder treatment for adults in the U.S. The company already has approval to market the drug for treatment of children and says it will begin marketing to adults immediately. Adderall XR is the most-prescribed brand for ADHD treatment in the states, and Shire says sales to adults could be double that for children.

View Full Article in:

Scotsman (Edinburgh), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ